Skip to main content
. 2017 Mar 30;312(6):G628–G634. doi: 10.1152/ajpgi.00455.2016

Table 1.

Intermediate filament proteins

Type Proteins Expression Cell Compartment Examples of Associated Diseases
I K9–K28; K31–K40 (hair and nails) Epithelial tissues for K1–K28 EBS (K5/K14); predisposition to acute or chronic liver disease (K8/K18/K19)
II K1–K8; K71–K86 (hair and nails) (obligate type I–II heteropolymers)
III Vimentin Mesenchymal cells, including lens Cataracts
GFAP Glial cells Alexander disease
Desmin Muscle cells Desmin-related myopathy
Syncoilin Muscle cells Unknown
Peripherin Peripheral neurons Amyotrophic later sclerosis
IV Neurofilaments (light, medium, and heavy: NF-L, NF-M, and NF-H) CNS neurons CMT type 2; amyotrophic lateral sclerosis (predisposition)
α-Internexin CNS neurons Unknown
Nestin Stem and neuroepithelial cells Unknown
Synemin Muscle cells Unknown
V Lamins Nuclei FPLD2 (lamin A/C); APL (lamin B2)
VI Bfsp1 (filensin); Bfsp2 (CP49) Eye lens Juvenile-onset cataracts

For some of the IFs, only a few examples of associated diseases are listed (e.g., many other keratinopathies and laminopathies are not included, but none of these disorders are known to involve digestive organs).

APL, acquired partial lipodystrophy; Bfsp, beaded filament structural protein; CMT, Charcot-Marie-Tooth disease; CNS, central nervous system; CP49, cytoskeletal protein 49 kDa; EBS, epidermolysis bullosa simplex; FPLD2, Dunnigan familial partial lipodystrophy type 2; K, keratin.